7 th Annual GHA Compliance Officers Retreat September 3 – 5, 2014 Reynolds Plantation Greensboro, Georgia.

Slides:



Advertisements
Similar presentations
Rebecca M. Johnson, MNPL Mark Meye, CPA
Advertisements

CAH and FQHC: Friend or Foe Elizabeth Morgan Burrows, JD Chief Executive Officer Vermillion Parke Community Health Center June 7, 2011.
340b Drug Purchasing Opportunities for Critical Access Hospitals Todd Lemke, PharmD Paynesville Area Health Care System.
Medicaid Supplemental Payments
INTEGRITY ● ACCESS ● VALUE 1 The 340B Drug Pricing Program: The Basics Paul Shank Health & Human Services Consultant, Health Resources and Services Administration.
Chapter 6 Federal Regulation of Pharmacy Practice.
Optimizing The 340B Program Promoting Integrity, Access, & Value To deliver clinically and cost-effective pharmacy services This educational product created.
1099 new york avenue, nw | suite 530 | washington dc |
Uncompensated Care Maryland AAHAM December 19, 2014.
1 1 © 2013 SUNRx and MedImpact, Inc. All Rights Reserved. Confidential, proprietary and possible Trade Secret of SUNRx and MedImpact (See Slide #1) The.
340B Drug Pricing Program Annual Recertification for Hospitals
The Federal 340B Program Facts, Figures, Opportunities, and Pitfalls Presented By: Shrujal Patel M.S. RPh. MBA.
1 The 3 Ps of the 340B Drug Pricing Program: Participation, Pricing and Program Integrity CDR Krista M. Pedley, PharmD, MS Director U.S. Department of.
Optimizing The 340B Program Promoting Integrity, Access, & Value To deliver clinically and cost-effective pharmacy services This educational product created.
Program Integrity through 340B Compliance
340B Audit Experience Todd Karpinski, PharmD, MS, FASHP
Britten Pund, Senior Manager, Health Care Access Emily McCloskey, Manager, Policy and Legislative Affairs The Ryan White Program and 340B Pharmacies.
340b Program Background. Proprietary and Confidential. Do not distribute. General Overview What is the 340b program Recent legislative changes and the.
© Wipfli LLP 2015 HFMA Annual Update January 30, 2015.
Understanding the Healthy Michigan Plan. About 10 million more people have insurance this year as a result of the Affordable Care Act The biggest winners.
Covered Entity Search Start at Click on this link Select the entity type and enter data to find a specific entity.
Challenges and Opportunities Under The 340B Program Safety Net Hospitals for Pharmaceutical Access Ted Slafsky, Executive Director May 10, 2010, 4:00-5:00.
We’re a 340B hospital… Now what?. 32 nd Magnet Hospital in the United States 260 bed acute care facility 5 county service area Catawba Valley Medical.
Working Together To Improve Access To Care Presentation to Center for Business Intelligence Patient Assistance Programs Conference March 11, 2003 Alexandria,
340B Drug Discount Program 2013 May 16, 2013 May 16,
340B: An Overview.
The 340B Program: An Overview NGA/NCSL Web-assisted Audioconference August 5, 2005 Diane P. Goyette, RPh, JD U.S. Department of Health and Human Services.
FY 2005 Indigent Care Trust Fund Disproportionate Share Hospital Program Presented to House Appropriations Health Subcommittee June 23, 2005.
State Opportunities under the 340B Drug Discount Program by Bill von Oehsen Counsel Public Hospital Pharmacy Coalition Phone:
Slide 1 Drug Pricing Considerations Medicare Prescription Drug, Improvement, and Modernization Act of 2003 ___________ Copyright 2005 Arnold & Porter July.
PwC Pharmaceutical Drug Pricing and Reporting Issues A Brief Overview of Government Drug Price Reporting Requirements July 28, 2005 National Parma Audioconference.
Understanding Federally Qualified Health Centers and Federally Qualified Health Center Look-Alikes Tonya Bowers, MHS Department of Health and Human Services.
Draft Model Manufacturer Agreement Medicare Coverage Gap Discount Program Public Meeting June 1, 2010.
GOVERNMENT CONTRACTS: FALSE CLAIMS AND COMPLIANCE Robert M. Jenkins III Mayer, Brown & Platt Presentation To The Fifth Annual National Congress on Health.
HIT FINAL EXAM REVIEW HI120.
EHealthUniversity1 Virtual Health Center, Inc PHS 340B Pricing Program August 21, 2014 Dr. Erica Watkins,PharmD, RPh Vice President, Business Development.
340B PRICING AND PROCUREMENT ELIGIBILITY, ENROLLMENT, AND REQUIREMENTS Virtual Health Center’s eHealthUniversity Dr. Erica C. Watkins, PharmD, RPh August.
© 2014 SUNRx, Inc. All rights reserved. NCHA and SUNRx MegaGuidance Overview October 19,
CPSP Reimbursement Models PSC Annual Meeting November 7, 2012.
340B DRUG DISCOUNT PROGRAM ARNETT CARBIS TOOTHMAN LLP © 2015, Arnett Carbis Toothman Arnett Carbis Toothman llp 101 Washington St. East Charleston, WV.
California’s New Compliance Law Kelly N. Reeves
Optimizing The 340B Program Promoting Integrity, Access, & Value To deliver clinically and cost-effective pharmacy services This educational product created.
FY 2005 Indigent Care Trust Fund Disproportionate Share Hospital Program Presented to Board of Community Health January 13, 2005.
America’s Voice for Community Health Care The National Association of Community Health Centers (NACHC) represents Community and Migrant Health Centers,
B ASICS OF 340B Lynn Ford Purchasing Program Coordinator Texas Association of Community Health Centers October 7, 2014.
Year in Review and What to Expect in B Drug Discount Program: Year in Review and What to Expect in 2016 Erin Estey Hertzog, JD, MPH Biotechnology.
Georgia Legal Services Program Indigent Care Trust Fund HELP FOR HOSPITALS HELP FOR PATIENTS Linda S. Lowe GLSP Health Policy Specialist.
Office of Pharmacy Affairs 340B Drug Pricing Program Bradford R. Lang JD, MPH Public Health Analyst US Dept. of Health and Human Services Health Resources.
340B Update David Pointer, President SolutionsRx HFMA Joint Fall Conference (Show-Me, Heart of America, Greater St. Louis Chapters) October 23, 2015 Mega.
340B PROGRAM AND BEST PRICE LAW HIGPA 2003 National Pharmacy Forum February 4, 2003 Presentation By Ted Slafsky Director Public Hospital Pharmacy Coalition.
4147 N Ravenswood Ave, Ste.200 Chicago, IL | Compliance Round-Up September 8, 2015 Today’s 340B Focus: Disproportionate.
Medicaid Influence in the Drug Market Dana Costea PhD student, Department of Economics, Lehigh University Franklin Carter Assistant Professor, Marketing.
340B Introduction Session by Bill von Oehsen President and General Counsel Safety Net Hospitals for Pharmaceutical Access 340B Workshop & Networking Luncheon.
Presenter Name Tim Mallett, RPh Director, 340B & Community Health 340B Updates, Audits & Future State.
The Pharmacy Technician 4E
340B Audit Technician Practice: Drilling for the Data
Regional Meeting Southeast May 20th 2013 Sean Singh Vice President
August 14, 2012 CDR Krista M. Pedley, PharmD, MS Director
The Institution and HTC 340B Program Relationship
HRSA Audit – Survivors or Casualties?
Hemophilia Alliance Fall Meeting 2017
Demystifying 340B: Frequently Asked Questions
340B Drug Discount Program
340B Auditing and Monitoring Are You Ready for HRSA
The basics of 340(b) pharmacy pricing for human resource managers
340B: Overview of the Program and Legislative Update
LEVERAGING PURCHASED/REFERRED CARE (PRC) RATES
340B basics & 340B value to HCV treatment
2018 Institutional Cost Report (ICR) Updates NYS Department of Health
Ryan Witz VP, Healthcare Financing Initiatives
Presentation transcript:

7 th Annual GHA Compliance Officers Retreat September 3 – 5, 2014 Reynolds Plantation Greensboro, Georgia

340B Participation?

What is your role?

10 MINUTE QUICK TOUR

Program intent To permit covered entities “to stretch scarce Federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.” H.R. Rep. No (II), at 12 (1992)

What is the 340B Drug Program? Section 340B of the Public Health Service Act requires drug manufacturers who wished to sell drugs to the Medicaid program to provide reduced pricing.

What is the 340B Drug Program? Reduced pricing applies only to – covered entities, – covered patients, and – covered outpatient drugs.

What is a covered entity? Facilities or programs listed in the 340B Statute as eligible to purchase drugs through the 340B Program and appear on the Office of Pharmacy Affairs Database (OPA). – A pharmacy is not an eligible 340B covered entity.

Which entities can participate? Hospitals – Disproportionate Share Hospitals – Children’s Hospitals – Freestanding Cancer Hospitals – Rural Referral Centers – Sole Community Hospitals – Critical Access Hospitals Community Health Centers/FQHCs Certain specialized clinics (STD, HIV, etc.)

Hospital DSH percentage? Certain hospitals must meet disproportionate share adjustment percentages for the most recent cost reporting period before the calendar quarter involved: – Disproportionate Share, Children’s, Free Standing Cancer: > 11.75% – Sole Community, Rural Referral Center: ≥ 8% – CAH – no DSH requirement

Additional requirements? Additional requirements for hospitals – Must be owned and operated by state or local government, or – Private, non-profit under contract with state to provide care to indigent populations, or – Be granted governmental powers Formal recognition to provide healthcare for medically indigent population in state

What is a covered entity? Facilities or programs listed in the 340B Statute as eligible to purchase drugs through the 340B Program and appear on the Office of Pharmacy Affairs Database (OPA). – A pharmacy is not an eligible 340B covered entity.

OPA database

Compliance look-out Inaccurate OPA database information – 26% of 2013 HRSA audits – 29% of 2012 HRSA audits – Addresses, contacts, terminated covered entities, contract pharmacies

How can this happen?

What is a covered drug? An FDA-approved prescription drug, an over- the-counter (OTC) drug that is written on a prescription, a biological product that can be dispensed only by a prescription (other than a vaccine), or FDA-approved insulin Drugs can only be dispensed to qualifying outpatients.

Compliance look-out How can this happen?

1996 definition

Compliance look-out How can this happen?

Compliance look-out Ineligible patient Ineligible prescriber Referrals?

Are employees 340B eligible?

GPO Prohibition Applies to DSH, PEDs and CANs Does not apply to CAHs, SCHs, RRCs

Why a GPO prohibition? Manufacturers feel that if a hospital is getting the 340B deep discount on covered outpatient drugs, it should not be entitled to additional GPO discounts for covered outpatient drugs. 34OB and GPO

Compliance look-out Which areas in the hospital system use drugs purchased under GPO contracts? – Inpatient only areas – Non-provider-based areas outside of four walls – Inside four walls ONLY if not legally part of the covered entity

GPO tracking requirements

Manual inventories Prospective purchase methodology – Drugs purchased at the 340B discount price will kept physically separate from all other drugs – Drugs will be taken from the 340B manual inventory when needed to dispense to an eligible patient – Beginning and ending inventory counts should be reconciled considering purchases and eligible patient usage

Manual inventories Purchase drugs at 340B prices Maintain in a physically separate inventory Issue drug to eligible patient Chart/track use of drug GPO ?

Audit requirements Beginning InventoryPurchasesDispensations Returns/AdjustmentsEnding Inventory

Compliance look-out Do any of the 340B entities maintain manual inventories? Can they be reconciled from purchase to dispense/administration to a patient?

Virtual inventories Replenishment methodology – Drugs purchased at 340B discount can be commingled with other drugs – Drugs will be dispensed to patient, and dependent upon patient type, will be tracked as a 340B dispense (use tracking software) – 340B dispensations will be used to support future 340B purchases

Tracking dispensations for support Dispensations or claims feed

Drug purchasing audit trail Must have supporting dispensations to support orders 340B GPO

Compliance look-out Are dispensations in 340B tracking software (GPO and 340B) tested routinely for: – Drug conversion accuracy – Dosage compared to medical chart – Location of patient at time of dispense – Posting of ALL purchases – NDC matching

NDC matching

NDC tracking requirements Drugs purchased to replace stock used on 340B eligible patients must bear the same National Drug Code (NDC) 11-digit match as the one dispensed. Exceptions are very limited and can be replenished only in cases where only a 9 digit match is available. This NDC-to-NDC match is difficult and sometimes impossible to achieve.

Multiple NDCs Drug – ABC is purchased using two NDCs. NDC 1 NDC How do I know which NDC was given to patient? Since we don’t use bar codes, I will have to use one NDC as the proxy.

Primary NDC Primary NDC – most common 340B purchase Less common versions of same drug - Secondary NDC A Secondary NDC B Secondary NDC C Dispensations flow to accumulator with this NDC for 340B replenishment Actual NDCs will not flow to accumulator until designated as the primary. Cannot be replenished under 340B until shows up in accumulator.

Compliance look-out How often are primary NDCs revised? – Dispense “feed” to accumulator – Charge “feed” to accumulator Are only “exact” 11-digit matches used in replenishment, or are “substitutions” used? How often are 340B/GPO replenishments tested for support?

Compliance look-out

WHAT’S THE FUSS? There are savings up to 50% on drug costs.

340B Volume of 340B purchases Use of contract pharmacies Public comments regarding 340B participation Prior history

340B avg. annual savings - $31.7 million

Contract pharmacies Are contract pharmacy arrangements profitable?

Summary Understand the compliance risks Participate in monitoring and audits Educate yourself and staff Keep a look-out for Program changes

For more information Cindy DuPree, CPA Sarah Dekutowski, CPA